# The Comparison Between the Biomarkers in Inflammatory Bowel Disease Patients and General Control Group

> **NCT03778918** · — · UNKNOWN · sponsor: **Bo-In Lee** · enrollment: 200 (estimated)

## Conditions studied

- Inflammatory Bowel Diseases
- Irritable Bowel Syndrome

## Interventions

- **OTHER:** inflammatory bowel disease
- **OTHER:** IBS or Normal Control

## Key facts

- **NCT ID:** NCT03778918
- **Lead sponsor:** Bo-In Lee
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-08-01
- **Primary completion:** 2020-06-30
- **Final completion:** 2020-12-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2020-03-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03778918

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03778918, "The Comparison Between the Biomarkers in Inflammatory Bowel Disease Patients and General Control Group". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03778918. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*